Neuland Laboratories Quarterly Results for Trading Insights
NEULANDLAB • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹97 Cr
QSept 2025
Neuland Laboratories Quarterly Results Key Highlights
- Revenue of ₹516 Cr in Sept 2025 (+53.6% vs Mar 2025, +63.8% vs Sept 2024)
- Net Profit of ₹97 Cr in Sept 2025 (+246.4% vs Mar 2025, +193.9% vs Sept 2024)
- EBITDA of ₹157 Cr in Sept 2025 (+166.1% vs Mar 2025)
- Operating Margin of 30.0% in Sept 2025 (+14.0pp vs Mar 2025)
- Earnings Per Share of ₹75.49 in Sept 2025 (+248.4% vs Mar 2025)
Neuland Laboratories Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 516 | 336 | 301 | 315 | 390 | 53.6% | 63.8% |
| Net Profit (₹ Cr) | 97 | 28 | 14 | 33 | 68 | - | - |
| EBITDA (₹ Cr) | 157 | 59 | 42 | 67 | 112 | - | - |
| EPS (₹) | 75.49 | 21.67 | 10.83 | 25.60 | 52.66 | - | - |
| Operating Margin (%) | 30.0% | 16.0% | 12.0% | 20.0% | 28.0% | - | - |
Neuland Laboratories Share Price Trend Around Quarterly Results
Visualize Neuland Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Neuland Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Neuland Laboratories
Additional stock information and data for NEULANDLAB
Revenue Trend (₹ Cr)
Sept 2024
315
Jun 2025
301
Mar 2025
336
Sept 2025
516
Net Profit Trend (₹ Cr)
Sept 2024
33
Jun 2025
14
Mar 2025
28
Sept 2025
97
Operating Margin Trend (%)
Sept 2024
20.0%
Jun 2025
12.0%
Mar 2025
16.0%
Sept 2025
30.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Neuland Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores